Kimball Electronics Reports Q2 Results; With Strong Sales Growth in the Medical Vertical; Company Raises Its Guidance for Fiscal 2026
MWN-AI** Summary
Kimball Electronics, Inc. (Nasdaq: KE) announced its financial results for the second quarter of fiscal 2026, reporting revenue of $341.3 million. This figure reflects a 5% decrease compared to the same period in fiscal 2025. Notably, the medical vertical demonstrated robust growth, with a 15% increase year-over-year, contributing to the company’s overall sales. Operating income rose from $8.2 million to $10.8 million, translating to 3.2% of net sales, while adjusted operating income improved to 4.5%, a notable increase of 80 basis points from the previous year.
The company's cash from operations reached $6.9 million, marking its eighth consecutive quarter of positive cash generation, bolstered by improved Cash Conversion Days, which saw a 16-day reduction to 91 days. The adjusted net income for the quarter was $6.9 million, providing a diluted earnings per share of $0.15.
Reflecting on the performance, CEO Richard D. Phillips expressed satisfaction with the results and highlighted the company’s strategic direction as a medical Contract Manufacturing Organization (CMO). He indicated that the medical sector's growth is outperforming other verticals and described efforts to rebalance their market portfolio. This includes the recent rebranding to Kimball Solutions and the inauguration of a new medical manufacturing facility in Indianapolis.
In light of the strong performance, Kimball Electronics raised its fiscal 2026 guidance, now projecting net sales between $1.4 billion and $1.46 billion, compared to the earlier range of $1.35 billion to $1.45 billion. Adjusted operating income is also expected to improve, now estimated between 4.2% and 4.5%. The positive outlook is supported by the company's strategic investments and operational improvements.
MWN-AI** Analysis
Kimball Electronics, Inc. recently reported its Q2 fiscal 2026 results, showcasing a unique performance landscape. Despite an overall revenue decline of 5% year-over-year, the medical vertical reported an impressive 15% increase in sales. This is significant, as the medical sector is anticipated to outperform other business segments, solidifying Kimball's focus on expanding its capabilities in this high-demand area.
With operating income improving both on a reported basis (3.2% vs. 2.3% year-over-year) and adjusted (4.5% vs. 3.7% year-over-year), Kimball demonstrates robust operational efficiency. The positive cash flow from operations for the eighth consecutive quarter underscores its solid financial foundation. Furthermore, the recent share repurchase of 149,000 shares indicates management's confidence in the company's ongoing performance and its perceived value in the market.
Notably, Kimball has raised its guidance for net sales in fiscal 2026 to a range of $1.4-$1.46 billion, signaling a proactive approach amidst current economic uncertainties. The predicted adjusted operating income margin has also increased, highlighting management’s commitment to sustaining profitability.
Investors should consider the long-term potential of Kimball Electronics, particularly within the medical sector. The company’s strategic pivot, evident from the rebranding efforts and the opening of the new medical facility in Indianapolis, positions it favorably in a growing market.
For those looking at investment opportunities, Kimball Electronics may present a compelling case, especially with its strengthened guidance and expanding capabilities. However, as with all investments, potential investors should remain mindful of industry competition and broader economic conditions that could impact performance. Monitoring quarterly results closely will be crucial to gauge sustained growth and operational efficiency.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Second Quarter 2026 Highlights
- Revenue of $341.3 million, a 5% decrease compared to Q2 of fiscal 2025
- Sales in the medical vertical increased 15% year-over-year
- Operating income of $10.8 million, or 3.2% of net sales
- Adjusted operating income of 4.5%, up 80 bps year-over-year
- Cash from operations of $6.9 million, the eighth consecutive quarter of positive operating cash generation
- Debt of $154.2 million and borrowing capacity of $285.1 million
- Cash Conversion Days of 91, a 16-day improvement compared to the same period last year
- Invested $4.3 million to repurchase 149,000 shares of common stock
- Company increases guidance for fiscal 2026 sales and adjusted operating income
Kimball Electronics, Inc. (Nasdaq: KE) today announced financial results for the second quarter ended December 31, 2025.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260204163117/en/
Three Months Ended | Six Months Ended | ||||||||||||||
December 31, | December 31, | ||||||||||||||
(Amounts in Thousands, except EPS) | 2025 | 2024 | 2025 | 2024 | |||||||||||
Net Sales | $ | 341,280 | $ | 357,392 | $ | 706,883 | $ | 731,648 | |||||||
Operating Income | $ | 10,767 | $ | 8,230 | $ | 25,221 | $ | 17,345 | |||||||
Adjusted Operating Income (non-GAAP) | $ | 15,308 | $ | 13,333 | $ | 32,842 | $ | 25,923 | |||||||
Operating Income % | 3.2 | % | 2.3 | % | 3.6 | % | 2.4 | % | |||||||
Adjusted Operating Income (non-GAAP) % | 4.5 | % | 3.7 | % | 4.6 | % | 3.5 | % | |||||||
Net Income | $ | 3,637 | $ | 3,432 | $ | 13,723 | $ | 6,586 | |||||||
Adjusted Net Income (non-GAAP) | $ | 6,925 | $ | 7,354 | $ | 19,175 | $ | 12,881 | |||||||
Diluted EPS | $ | 0.15 | $ | 0.14 | $ | 0.55 | $ | 0.26 | |||||||
Adjusted Diluted EPS (non-GAAP) | $ | 0.28 | $ | 0.29 | $ | 0.77 | $ | 0.51 |
Commenting on today’s announcement, Richard D. Phillips, Chief Executive Officer, stated, “I’m pleased with the results for the second quarter and our updated guidance for fiscal 2026. Sales in Q2 were in line with expectations, highlighted by another quarter of strong double-digit year-over-year growth in the medical vertical, margins improved compared to the same period last year, and cash from operations was positive for the eighth consecutive quarter.”
Mr. Phillips continued, “Our focus as a medical CMO continues to gain momentum as we leverage our unique capabilities in the industry. We expect top-line growth in medical to outpace our other two verticals as we balance our portfolio across the markets we serve. Our recent announcement to rebrand as Kimball Solutions, and the grand opening of the new medical manufacturing facility in Indianapolis, reflects this strategy and our expanded offering of capabilities and services.”
Net Sales by Vertical Market for Q2 Fiscal 2026:
Three Months Ended | Six Months Ended | |||||||||||||||||||||||||||||||
December 31, | December 31, | |||||||||||||||||||||||||||||||
(Amounts in Millions) | 2025 | * | 2024 (2) | * | Percent | 2025 | * | 2024 (2) | * | Percent | ||||||||||||||||||||||
Automotive | $ | 162.3 | 48 | % | $ | 186.3 | 52 | % | (13 | )% | $ | 326.7 | 46 | % | $ | 368.0 | 50 | % | (11 | )% | ||||||||||||
Medical | 96.3 | 28 | % | 84.0 | 23 | % | 15 | % | 197.9 | 28 | % | 173.8 | 24 | % | 14 | % | ||||||||||||||||
Industrial excluding AT&M (1) | 82.7 | 24 | % | 87.1 | 25 | % | (5 | )% | 182.3 | 26 | % | 187.7 | 26 | % | (3 | )% | ||||||||||||||||
Net Sales excluding AT&M (1) | $ | 341.3 | 100 | % | $ | 357.4 | 100 | % | (5 | )% | $ | 706.9 | 100 | % | $ | 729.5 | 100 | % | (3 | )% | ||||||||||||
AT&M (1) | — | — | % | — | — | % | — | % | — | — | % | 2.1 | — | % | (100 | )% | ||||||||||||||||
Total Net Sales | $ | 341.3 | 100 | % | $ | 357.4 | 100 | % | (5 | )% | $ | 706.9 | 100 | % | $ | 731.6 | 100 | % | (3 | )% |
* | As a percent of Total Net Sales |
(1) | Sales from our Automation, Test, and Measurement business (AT&M), which was divested effective July 31, 2024, were previously included in the industrial vertical |
(2) | Beginning in the first quarter of fiscal year 2026, sales to customers related to commercial transportation, previously included in the automotive vertical, are now reflected in the industrial vertical; prior periods have been recast to conform to current period presentation |
- | Automotive includes electronic power steering, body controls, advanced driver-assistance systems, and electronic braking systems |
- | Medical includes sleep therapy and respiratory care, image guided therapy, in vitro diagnostics, drug delivery, AED, and patient monitoring |
- | Industrial includes climate controls, automation controls, public safety, IoT and factory automation, efficient energy, off highway equipment, and commercial transportation |
Fiscal Year 2026 Guidance
As part of today’s announcement, the Company increased its guidance for net sales and adjusted operating income in fiscal year 2026:
- Net sales are now expected to be in the range of $1,400 - $1,460 million, compared to the previous guidance of $1,350 - $1,450 million
- Adjusted operating income is estimated to be 4.2% - 4.5% of net sales versus the prior estimate of 4.0% - 4.25%
- The guidance for capital expenditures did not change with a range of $50 - $60 million
Conference Call / Webcast |
Date: Thursday, February 5, 2026 Time: 10:00 AM Eastern Time Live Webcast: investors.kimballelectronics.com/events-and-presentations/events Dial-in #: 877-407-8293 (or 201-689-8349) For those unable to participate in the live webcast, the call will be archived at investors.kimballelectronics.com . |
Forward-Looking Statements
Certain statements contained within this release are considered forward-looking, including our guidance, under the Private Securities Litigation Reform Act of 1995. The statements may be identified by the use of words such as “expect,” “should,” “goal,” “predict,” “will,” “future,” “optimistic,” “confident,” and “believe.” Undue reliance should not be placed on these forward-looking statements. These statements are based on current expectations of future events and thus are inherently subject to uncertainty. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from our expectations and projections. These forward-looking statements are subject to risks and uncertainties including, without limitation, global economic conditions, geopolitical environment and conflicts such as the war in Ukraine, global health emergencies, availability or cost of raw materials and components, tariffs and other trade barriers, foreign exchange rate fluctuations, and our ability to convert new business opportunities into customers and revenue. Additional cautionary statements regarding other risk factors that could have an effect on the future performance of the company are contained in its Annual Report on Form 10-K for the year ended June 30, 2025.
Non-GAAP Financial Measures
This press release contains non-GAAP financial measures. The non-GAAP financial measures contained herein include constant currency growth, net sales excluding Automation, Test & Measurement, adjusted selling and administrative expenses, adjusted operating income, adjusted net income, adjusted diluted EPS, and ROIC. Reconciliations of the reported GAAP numbers to these non-GAAP financial measures are included in the Reconciliation of Non-GAAP Financial Measures section below. Management believes these measures are useful and allow investors to meaningfully trend, analyze, and benchmark the performance of the company’s core operations. The company’s non-GAAP financial measures are not necessarily comparable to non-GAAP information used by other companies.
About Kimball Electronics, Inc.
Kimball Electronics is a global, multifaceted manufacturer offering Electronics Manufacturing Services (EMS) and Contract Manufacturing Organization (CMO) solutions to customers around the world. From our operations in the United States, China, Mexico, Poland, Romania, and Thailand, our teams are proud to provide manufacturing services for a variety of industries. Recognized for a reputation of excellence, we are committed to a high-performance culture that values quality, reliability, value, speed, and ethical behavior. Kimball Electronics, Inc. (Nasdaq: KE) is headquartered in Jasper, Indiana.
To learn more about Kimball Electronics, visit www.kimballelectronics.com .
Lasting relationships. Global success.
Condensed Consolidated Statements of Income | |||||||||||||
(Unaudited) | Three Months Ended | ||||||||||||
(Amounts in Thousands, except Per Share Data) | December 31, 2025 | December 31, 2024 | |||||||||||
Net Sales | $ | 341,280 | 100.0 | % | $ | 357,392 | 100.0 | % | |||||
Cost of Sales | 313,412 | 91.8 | % | 333,965 | 93.4 | % | |||||||
Gross Profit | 27,868 | 8.2 | % | 23,427 | 6.6 | % | |||||||
Selling and Administrative Expenses | 14,862 | 4.4 | % | 10,526 | 3.0 | % | |||||||
Restructuring Expense | 1,817 | 0.5 | % | 4,671 | 1.3 | % | |||||||
Asset Impairment | 422 | 0.1 | % | — | — | % | |||||||
Operating Income | 10,767 | 3.2 | % | 8,230 | 2.3 | % | |||||||
Interest Income | 375 | 0.1 | % | 253 | 0.1 | % | |||||||
Interest Expense | (2,095 | ) | (0.6 | )% | (4,241 | ) | (1.2 | )% | |||||
Non-Operating Income (Expense), net | (2,063 | ) | (0.7 | )% | (768 | ) | (0.2 | )% | |||||
Other Income (Expense), net | (3,783 | ) | (1.2 | )% | (4,756 | ) | (1.3 | )% | |||||
Income Before Taxes on Income | 6,984 | 2.0 | % | 3,474 | 1.0 | % | |||||||
Provision (Benefit) for Income Taxes | 3,347 | 0.9 | % | 42 | — | % | |||||||
Net Income | $ | 3,637 | 1.1 | % | $ | 3,432 | 1.0 | % | |||||
Earnings Per Share of Common Stock: | |||||||||||||
Basic | $ | 0.15 | $ | 0.14 | |||||||||
Diluted | $ | 0.15 | $ | 0.14 | |||||||||
Average Number of Shares Outstanding: | |||||||||||||
Basic | 24,606 | 24,870 | |||||||||||
Diluted | 24,823 | 24,968 |
(Unaudited) | Six Months Ended | ||||||||||||
(Amounts in Thousands, except Per Share Data) | December 31, 2025 | December 31, 2024 | |||||||||||
Net Sales | $ | 706,883 | 100.0 | % | $ | 731,648 | 100.0 | % | |||||
Cost of Sales | 650,179 | 92.0 | % | 684,621 | 93.6 | % | |||||||
Gross Profit | 56,704 | 8.0 | % | 47,027 | 6.4 | % | |||||||
Selling and Administrative Expenses | 27,952 | 3.9 | % | 23,953 | 3.2 | % | |||||||
Restructuring Expense | 3,233 | 0.5 | % | 6,993 | 1.0 | % | |||||||
Asset Impairment (Gain on Disposal) | 298 | — | % | (1,264 | ) | (0.2 | )% | ||||||
Operating Income | 25,221 | 3.6 | % | 17,345 | 2.4 | % | |||||||
Interest Income | 514 | 0.1 | % | 475 | 0.1 | % | |||||||
Interest Expense | (4,448 | ) | (0.6 | )% | (9,033 | ) | (1.2 | )% | |||||
Non-Operating Income (Expense), net | (3,304 | ) | (0.6 | )% | (2,429 | ) | (0.4 | )% | |||||
Other Income (Expense), net | (7,238 | ) | (1.1 | )% | (10,987 | ) | (1.5 | )% | |||||
Income Before Taxes on Income | 17,983 | 2.5 | % | 6,358 | 0.9 | % | |||||||
Provision (Benefit) for Income Taxes | 4,260 | 0.6 | % | (228 | ) | — | % | ||||||
Net Income | $ | 13,723 | 1.9 | % | $ | 6,586 | 0.9 | % | |||||
Earnings Per Share of Common Stock: | |||||||||||||
Basic | $ | 0.56 | $ | 0.26 | |||||||||
Diluted | $ | 0.55 | $ | 0.26 | |||||||||
Average Number of Shares Outstanding: | |||||||||||||
Basic | 24,603 | 24,924 | |||||||||||
Diluted | 24,878 | 25,098 |
| Condensed Consolidated Statements of Cash Flows | Six Months Ended | ||||||
(Unaudited) | December 31, | ||||||
(Amounts in Thousands) | 2025 | 2024 | |||||
Net Cash Flow provided by Operating Activities | $ | 14,943 | $ | 74,932 | |||
Net Cash Flow used for Investing Activities | (24,368 | ) | (1,214 | ) | |||
Net Cash Flow used for Financing Activities | (2,142 | ) | (97,255 | ) | |||
Effect of Exchange Rate Change on Cash, Cash Equivalents, and Restricted Cash | 623 | (722 | ) | ||||
Net Decrease in Cash, Cash Equivalents, and Restricted Cash | (10,944 | ) | (24,259 | ) | |||
Cash, Cash Equivalents, and Restricted Cash at Beginning of Period | 89,467 | 78,779 | |||||
Cash, Cash Equivalents, and Restricted Cash at End of Period | $ | 78,523 | $ | 54,520 |
(Unaudited) | |||||||
Condensed Consolidated Balance Sheets | December 31, | June 30, | |||||
(Amounts in Thousands) | |||||||
ASSETS | |||||||
Cash and cash equivalents | $ | 77,853 | $ | 88,781 | |||
Receivables, net | 213,994 | 222,623 | |||||
Contract assets | 79,521 | 71,812 | |||||
Inventories | 281,699 | 273,500 | |||||
Prepaid expenses and other current assets | 32,214 | 36,027 | |||||
Assets held for sale | 6,610 | 6,861 | |||||
Property and Equipment, net | 276,433 | 264,804 | |||||
Goodwill | 6,191 | 6,191 | |||||
Other Intangible Assets, net | 2,182 | 2,427 | |||||
Other Assets, net | 106,774 | 104,286 | |||||
Total Assets | $ | 1,083,471 | $ | 1,077,312 | |||
LIABILITIES AND SHARE OWNERS ’ EQUITY | |||||||
Current portion of long-term debt | $ | 24,112 | $ | 17,400 | |||
Accounts payable | 218,830 | 218,805 | |||||
Advances from customers | 28,439 | 35,867 | |||||
Accrued expenses | 41,995 | 46,489 | |||||
Long-term debt, less current portion | 129,700 | 129,650 | |||||
Other long-term liabilities | 61,233 | 59,217 | |||||
Share Owners’ Equity | 579,162 | 569,884 | |||||
Total Liabilities and Share Owners’ Equity | $ | 1,083,471 | $ | 1,077,312 |
Other Financial Metrics | ||||||||
(Unaudited) | ||||||||
(Amounts in Millions, except CCD) | ||||||||
At or For the | ||||||||
Three Months Ended | ||||||||
December 31, | September 30, | December 31, | ||||||
2025 | 2025 | 2024 | ||||||
Depreciation and Amortization | $ | 9.3 | $ | 9.1 | $ | 9.1 | ||
Cash Conversion Days (CCD) (1) | 91 | 83 | 107 | |||||
Open Orders (2) | $ | 557 | $ | 593 | $ | 564 |
(1) | Cash Conversion Days (“CCD”) are calculated as the sum of Days Sales Outstanding plus Contract Asset Days plus Production Days Supply on Hand less Accounts Payable Days and less Advances from Customers Days. CCD, or a similar metric, is used in our industry and by our management to measure the efficiency of managing working capital. |
(2) | Open Orders are the aggregate sales price of production pursuant to unfulfilled customer orders. |
| Select Financial Results of Automation, Test and Measurement | |||||||||||||
(Unaudited) | |||||||||||||
(Amounts in Millions) | |||||||||||||
Three Months Ended | Six Months Ended | ||||||||||||
December 31, | December 31, | ||||||||||||
2025 | 2024 | 2025 | 2024 | ||||||||||
Net Sales | $ | — | $ | — | $ | — | $ | 2.1 | |||||
Operating Income (Loss) (1) | $ | (0.4 | ) | $ | — | $ | (0.4 | ) | $ | 0.8 |
(1) | Amounts include gain (loss) on sale adjustments following the close of the sale on July 31, 2024: ($0.4 million) in the three and six months ended December 31, 2025 and $1.3 million for the six months ended December 31, 2024. |
Reconciliation of Non-GAAP Financial Measures | |||||||||||||||
(Unaudited, Amounts in Thousands, except Per Share Data) | |||||||||||||||
Three Months Ended | Six Months Ended | ||||||||||||||
December 31, | December 31, | ||||||||||||||
2025 | 2024 | 2025 | 2024 | ||||||||||||
Net Sales Growth (vs. same period in prior year) | (5 | )% | (15 | )% | (3 | )% | (15 | )% | |||||||
Foreign Currency Exchange Impact | 2 | % | — | % | 2 | % | — | % | |||||||
Constant Currency Growth | (7 | )% | (15 | )% | (5 | )% | (15 | )% | |||||||
Selling and Administrative Expenses, as reported | $ | 14,862 | $ | 10,526 | $ | 27,952 | $ | 23,953 | |||||||
Stock Compensation Expense | (2,217 | ) | (501 | ) | (3,780 | ) | (2,573 | ) | |||||||
SERP | (85 | ) | 69 | (310 | ) | (276 | ) | ||||||||
Adjusted Selling and Administrative Expenses | $ | 12,560 | $ | 10,094 | $ | 23,862 | $ | 21,104 | |||||||
Operating Income, as reported | $ | 10,767 | $ | 8,230 | $ | 25,221 | $ | 17,345 | |||||||
Stock Compensation Expense | 2,217 | 501 | 3,780 | 2,573 | |||||||||||
SERP | 85 | (69 | ) | 310 | 276 | ||||||||||
Restructuring Expense | 1,817 | 4,671 | 3,233 | 6,993 | |||||||||||
Asset Impairment (Gain on Disposal) | 422 | — | 298 | (1,264 | ) | ||||||||||
Adjusted Operating Income | $ | 15,308 | $ | 13,333 | $ | 32,842 | $ | 25,923 | |||||||
Net Income, as reported | $ | 3,637 | $ | 3,432 | $ | 13,723 | $ | 6,586 | |||||||
Stock Compensation Expense, After-Tax | 1,681 | 380 | 2,866 | 1,951 | |||||||||||
Restructuring Expense, After-Tax | 1,287 | 3,542 | 2,360 | 5,303 | |||||||||||
Asset Impairment (Gain on Disposal), After-Tax | 320 | — | 226 | (959 | ) | ||||||||||
Adjusted Net Income | $ | 6,925 | $ | 7,354 | $ | 19,175 | $ | 12,881 | |||||||
Diluted Earnings per Share, as reported | $ | 0.15 | $ | 0.14 | $ | 0.55 | $ | 0.26 | |||||||
Stock Compensation Expense | 0.07 | 0.01 | 0.12 | 0.07 | |||||||||||
Restructuring Expense | 0.05 | 0.14 | 0.09 | 0.21 | |||||||||||
Asset Impairment (Gain on Disposal) | 0.01 | — | 0.01 | (0.03 | ) | ||||||||||
Adjusted Diluted Earnings per Share | $ | 0.28 | $ | 0.29 | $ | 0.77 | $ | 0.51 | |||||||
Twelve Months Ended | |||||||||||||||
December 31, | |||||||||||||||
2025 | 2024 | ||||||||||||||
Operating Income, as reported | $ | 53,411 | $ | 30,522 | |||||||||||
Goodwill Impairment | — | 5,820 | |||||||||||||
SERP | 648 | 649 | |||||||||||||
Restructuring Expense | 7,230 | 9,379 | |||||||||||||
Asset Impairment (Gain on Disposal) | (829 | ) | 15,776 | ||||||||||||
Legal Settlements (Recovery) | — | (892 | ) | ||||||||||||
Stock Compensation Expense | 7,726 | 6,096 | |||||||||||||
Adjusted Operating Income | $ | 68,186 | $ | 67,350 | |||||||||||
Tax Effect | 23,836 | 17,019 | |||||||||||||
After-tax Adjusted Operating Income | $ | 44,350 | $ | 50,331 | |||||||||||
Average Invested Capital (1) | $ | 657,074 | $ | 756,966 | |||||||||||
ROIC | 6.7 | % | 6.6 | % |
(1) | Average invested capital is computed using Share Owners’ equity plus current and non-current debt less cash and cash equivalents averaged for the last five quarters. |
View source version on businesswire.com: https://www.businesswire.com/news/home/20260204163117/en/
Andrew D. Regrut
Vice President, Investor Relations, Strategic Development, and Treasurer
812.827.4151
Investor.Relations@kimballelectronics.com
FAQ**
How is Kimball Electronics Inc. (Nasdaq: KE) planning to leverage the 15% year-over-year growth in sales within the medical vertical to offset the overall revenue decline observed in Q2 fiscal 2026?
Can you elaborate on how Kimball Electronics Inc. (KE) intends to utilize the $285.1 million borrowing capacity to strengthen its operational strategies moving forward?
Given the forecasted increase in net sales to $1.4 billion - $1.46 billion for fiscal 2026, what specific initiatives is Kimball Electronics Inc. (KE) implementing to maintain this growth trajectory amidst fluctuating economic conditions?
How will Kimball Electronics Inc. (Nasdaq: KE) address the challenges presented by the global economic environment and raw material costs to achieve the adjusted operating income target of 4.2% - 4.5% in fiscal year 2026?
**MWN-AI FAQ is based on asking OpenAI questions about Kimball Electronics Inc. (NASDAQ: KE).
NASDAQ: KE
KE Trading
5.83% G/L:
$23.145 Last:
37,255 Volume:
$22.79 Open:
